Abstract:Enzymatic hydrolysis of bovine and human hemoglobin generates a diversity of bioactive peptides, mainly recognized for their antimicrobial properties. However, antimicrobial peptides stand out for their ability to specifically target cancer cells while preserving rapidly proliferating healthy cells. This study focuses on the production of bioactive peptides from hemoglobin and evaluates their anticancer potential using two distinct approaches. The first approach is based on the use of a rapid screening method aimed at blocking host cell protein synthesis to evaluate candidate anticancer peptides, using Lepidium sativum seed germination as an indicator. The results show that: (1) The degree of hydrolysis (DH) significantly influences the production of bioactive peptides. DH levels of 3 to 10% produce a considerably stronger inhibition of radicle growth than DH 0 (the native form of hemoglobin), with an intensity three to four times greater. (2) Certain peptide fractions of bovine hemoglobin have a higher activity than those of human hemoglobin. (3) The structural characteristics of peptides (random coil or alpha helix) play a crucial role in the biological effects observed. (4) The α137-141 peptide, the target of the study, was the most active of the fractions obtained from bovine hemoglobin (IC50 = 29 ± 1 µg/mL) and human hemoglobin (IC50 = 48 ± 2 µg/mL), proving to be 10 to 15 times more potent than the other hemoglobin fractions, attributed to its strong antimicrobial potential. The second approach to assessing anticancer activity is based on the preliminary in vitro analysis of hydrolysates and their peptide fractions, with a focus on the eL42 protein. This protein is of major interest due to its overexpression in all cancer cells, making it an attractive potential target for the development of anticancer molecules. With this in mind, astudy was undertaken using a method for labeling formylase (formyl-methionyl-tRNA transformylase (FMTS)) with oxidized tRNA. This approach was chosen because of the similarities in the interaction between formylase and the eL42 protein with oxidized tRNA. The results obtained not only confirmed the previous conclusions but also reinforced the hypothesis that the inhibition of protein synthesis plays a key role in the anticancer mechanism of these peptides. Indeed, the data suggest that samples containing α137-141 peptide (NKT) and total hydrolysates may have modulatory effects on the interaction between FMTS and oxidized tRNA. This observation highlights the possibility that the latter could influence molecular binding mechanisms, potentially resulting in a competitive situation where the ability of substrate tRNA to bind efficiently to ribosomal protein is compromised in their presence. Ultimately, these results suggest the feasibility of obtaining candidate peptides for biological anticancer drugs from both human and bovine hemoglobin sources. These scientific advances show new hope in the fight against cancer, which affects a large number of people around the world.

Role of Glycosylation in the Anticancer Activity of Antibacterial Peptides Against Breast Cancer Cells

Glycosylated modification of MUC1 maybe a new target to promote drug sensitivity and efficacy for breast cancer chemotherapy

Progress of Glycomics in Breast Cancer

Correlation Between the Secondary Structure and Surface Activity of Β-Sheet Forming Cationic Amphiphilic Peptides and Their Anticancer Activity.

Effects of Glycosylation and d -Amino Acid Substitution on the Antitumor and Antibacterial Activities of Bee Venom Peptide HYL

Effect of Hydrophobicity on Distinct Anticancer Mechanism of Antimicrobial Peptide Chensinin-1B and Its Lipoanalog PA-C1b in Breast Cancer Cells

Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates

A Review for Antimicrobial Peptides with Anticancer Properties: Re-purposing of Potential Anticancer Agents

[Progress in the Mechanisms of Anticancer Peptides].

Targeted glycan degradation potentiates the anticancer immune response in vivo

Design, Synthesis, and Biological Evaluation of Novel Cholesteryl Peptides with Anticancer and Multidrug Resistance‐Reversing Activities

P18: Novel Anticancer Peptide from Induced Tumor-Suppressing Cells Targeting Breast Cancer and Bone Metastasis

Obtaining New Candidate Peptides for Biological Anticancer Drugs from Enzymatic Hydrolysis of Human and Bovine Hemoglobin

Antitumor Activity of Antimicrobial Peptides Containing CisoDGRC in CD13 Negative Breast Cancer Cells

N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting with Cell Membrane and Targeting Mitochondria in Breast Cancer Cells

Molecular mechanisms of antibacterial and antitumor actions of designed surfactant-like peptides.

Functional Properties of a Novel Hybrid Antimicrobial Peptide NS: Potent Antitumor Activity and Efficient Plasmid Delivery.

A Review on Structure, Bioactivity, Mechanism, Structure-Activity Relationship and Application of Anti-Breast Cancer Polysaccharides

Insights into the Role of Sialylation in Cancer Metastasis, Immunity, and Therapeutic Opportunity

Molecular Mechanisms Of Anticancer Action And Cell Selectivity Of Short Alpha-Helical Peptides

Antioxidant Stress and Anticancer of Peptide Chelate Selenium Element in vitro